1. Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?. Issue 5 (1st February 2018) Authors: Hinder, Markus; Yi, B. Alexander; Langenickel, Thomas H. Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 5(2018) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. (19th November 2021) Authors: Yi, B. Alexander; Freedholm, Debra; Widener, Nancy; Wang, Xiaohui; Simard, Emilie; Cullen, Constance; Al‐Saady, Naab M.; Lepor, Norman E.; Coulter, Sara; Lovern, Mark; Bloomfield, Dan Journal: Journal of thrombosis and haemostasis Issue: Volume 20:Number 2(2022) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗